192Ir intraluminal brachytherapy for the prevention of urethral re-stricture
- VernacularTitle:192Ir腔内放疗预防男性尿道内切开术后再狭窄临床分析
- Author:
Changuo MA
;
Hui GUO
;
Chun DU
;
Keqiang YANG
- Publication Type:Journal Article
- Keywords:
Urethral stricture/brachytherapy;
192Ir;
Treatment outcome
- From:
Chinese Journal of Radiation Oncology
2008;17(5):361-363
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the safety and efficacy of 192Ir intraluminal brachytherapy for the prevention of urethral re-stricture after transurethral incision or transurethral resection of scar. Methods From Mar. 2004 to Jun. 2006,48 patients aging 18-81 years were treated by 192Ir intraluminal brachytherapy. The length of stricture(0.5-5.5 era) was≤3.0 cm in 90% of the patients. The stricture was caused by trauma in 23 patients and prostate hyperplasia operation in 19 patients. The cause of remaining 6 patients was unclear. All patients were diagnosed by urethra photograph or endoscopy. Radiotherapy was the initial treatment in 26 patients and the second time treatment in 22. The irradiation dose was from 14 Gy to 18 Gy.Results The median follow up was 10 months,and the total response rate was 98%. Only one patient recurred and received transurethral incision again. The uresis was fluency in 47 patients and the maximum flow rate was 13.9-36.4(19.2±10.3) ml/s. No secondary urethral bleeding or urethral cancer was observed.Conclusions Being a safe and feasible treatment, ,192Ir intraluminal brachytherapy following transurethral incision or transurethral resection of scar can effectively prevent urethral re-stricture.
